Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Aflibercept-based and Bevacizumab-based second line regim... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Aflibercept-based and Bevacizumab-based second line regimens in patients with metastatic colorectal cancer: propensity score weighted-analysis from a multicenter cohort.
0
Authors
Jessica Lucchetti
•
Alessandro Minelli
22 more
•
Giuseppe Tonini
Published
January 1, 2025
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Clinical Colorectal Cancer
Topics
Cancer Oncology
Internal Medicine
Surgery
Medicine
Cancer Oncology
Internal Medicine
Surgery
Propensity Score Matching
Show all topics
DOI
10.1016/j.clcc.2024.12.007
License
CC-BY
